Articles by James Calloway
Ukrop's Recall: Six Meals Pulled Over Metal Fragments, Grocers See Minimal Financial Risk
Ukrop's Homestyle Foods recalls six ready-to-eat meals over aluminum slivers, affecting Kroger and Food Lion. Financial impact appears minimal; no injuries reported.
Novo Nordisk ADR Slides Despite Strong Q2, Danish Shares Await Catch-Up
Novo Nordisk's ADR dropped 6.8% despite Q2 earnings surpassing forecasts, as investors weigh pipeline impairments and competitive pressures.
NRG Energy Tumbles 15.5% as EPS Miss Offsets EBITDA Surge
NRG Energy (NYSE:NRG) shares plunged 15.5% after Q2 adjusted EPS of $1.49 missed consensus, as higher interest and depreciation offset strong EBITDA growth from the LS Power acquisition.
Spotify Stock Rebounds as Premium Growth Outpaces Ad Weakness
Spotify shares rebounded Tuesday after a mixed Q2 report. Premium revenue surged 15%, but ad revenue grew only 1%. Q3 revenue guidance topped estimates, while user and profit outlooks fell short.
Vistra Shares Slide as NRG's Earnings Miss Raises Financing Concerns
Vistra shares dropped 6.7% as NRG's earnings miss highlighted rising financing costs. Vistra's stronger EBITDA-to-interest coverage offers some buffer, but the Cogentrix acquisition adds debt.
Wayfair Soars 27% as Operating Leverage Drives Q2 Cash Flow Surge
Wayfair's stock surged 27% after Q2 results beat expectations, with operating leverage delivering a 35.4% incremental margin and free cash flow up 30.9%.
Opendoor Stock Rises Ahead of Q2 Earnings as Investors Eye Margin Recovery
Opendoor (NASDAQ:OPEN) shares rose 4.6% ahead of Q2 results, with revenue forecast at $900 million and analysts watching margin improvement.
Plug Power Rises Ahead of Q2 Report as Cash Burn Takes Center Stage
Plug Power (PLUG) advanced 3.1% to $2.15 ahead of its Q2 earnings release on August 10. Analysts project revenue near $168 million, while cash burn concerns intensify after a 27% drop in unrestricted cash.
McDonald's Beats Q2 Earnings Despite Slowing U.S. Traffic
McDonald's beat Q2 earnings estimates with adjusted EPS of $3.38, but U.S. comparable sales rose only 0.8%, missing expectations. Loyalty sales grew over 20%.
Pfizer Beats Q2 Forecasts, Raises 2026 Sales Outlook
Pfizer's Q2 results beat expectations, driven by strong performance of key drugs, leading to a modest increase in its 2026 revenue forecast.
Caterpillar Q2 Earnings Crush Estimates, Stock Jumps 7.5%
Caterpillar (CAT) surged 7.5% premarket after Q2 adjusted EPS of $8.17 beat by 31.8% and revenue rose 24% to $20.54B, with construction leading growth and backlog at record $72.1B.